12 trends to be witnessed in 2019 : Pharma Outlook

-
What does 2019 have in store for Pharma? It was asked to industry Thought Leaders to name one disruptive trend or technology that will have a significant impact on the market in the year ahead.
Will pricing pressure lead to a shift in budget management? Is this the year for biosimilar approvals? Will we see continued M&A activity in the sector?


From life cycle management to AI, and Supergenerics to digital healthcare, listed are the Pharma and Biopharma trends about 2019.

1. Big Pharma Restructuring will Create Challenges and Opportunities

Jim Miller, Former President & Founder, PharmSource


2. Continued M&A in the CDMO and CMO Business Sector

Kevin Bottomley, Partner, Results Healthcare



3. 2019: The Year of AI

Gunjan Bhardwaj, CEO, Innoplexus



4. A Paradigm Shift in the Management of Pharmaceutical Budgets

Maarten Van Baelen, Market Access Director, Medicines for Europe



5. Value Added Medicines: Digital Healthcare to the Rescue

Aurelio Arias, Senior Consultant - European Thought Leadership, IQVIA



6. Industry 4.0 and Biopharma

Killian O’Driscoll, Director of Projects, NIBRT



7. Life Cycle Management

Alan Sheppard, Managing Director, Ascher Resources



 8. Robust Growth for China's Biopharma Market

Vicky Xia, BioPlan Associates


9. Better Treatments Through a Deeper Understanding of Patients’ Needs

Will Downie, Senior Vice President, Global Sales & Marketing, Catalent Pharma Solutions



10. Industry-Wide Consolidation

Brandon Boyd, Director, Strategy & Thought Leadership - Life Sciences, Clarivate Analytics



11. A Big Year for Biosimilar Approvals

Fiona Barry, Associate Editor, PharmSource, a GlobalData product



12. Supergenerics with the Potential to Outperform New Chemical Entities

Paul Thorning, CEO, Crystec Pharma



Comments

Post a Comment

Popular posts from this blog

China-India joint summit discusses bilateral trade to improve pharma industry

-
The China-India joint summit held recently discussed bilateral trade to improve Indo- China pharma industry and address issues like long product registration time and high fees for product registration in China’s drug regulatory system, among other issues.  Besides this, other relevant key issues related to transparency in public procurement system in China and clinical trial related approvals were also deliberated at the summit organised under the aegis of Indian Pharmaceutical Association (IPA), Shengjie and SaSPinjara, China between May 16 and May 17, 2019 at Pullman Shanghai South, China. The summit was focused on enhancing export business for both the nations across the globe. Senior health ministry official from Government of Gujarat Punamchand Parmar was invited as the Chief Guest of the summit and Gujarat Food and Drugs Control Administration (FDCA) Commissioner Dr Hemant Koshia was invited as Guest of Honour.  Among other dignitaries, Dr. Anil Kumar Rai, Consulate General of
Read more

Webinar on ‘OPPORTUNITY TO COMMERCIALIZE HERBAL RESEARCH’

-
Image
“IDEA TO MARKET” is an idea hunt to commercialize the herbal inventions. It is a platform for researchers to use their innovative ideas in the area of herbal research and get the products commercialized in collaboration with corporate partners.  Hurry up and register for the webinar to know more about this program. The webinar is organized by Bombay College of Pharmacy and Pharma Literati.  Registration Link for webinar on OPPORTUNITY TO COMMERCIALIZE HERBAL RESEARCH: https://docs.google.com/forms/d/e/1FAIpQLSfUhe1LtCOjG50SilFw_iECnzBXu4CW0nK2wIvd8QVVvpDOzQ/viewform
Read more